Holen Sie sich die Stockscreener-App
20.84
0.31%
0.065
Schlusskurs vom Vortag:
$20.78
Offen:
$20.97
24-Stunden-Volumen:
988.32K
Relative Volume:
0.37
Marktkapitalisierung:
$5.26B
Einnahmen:
$773.78M
Nettoeinkommen (Verlust:
$155.51M
KGV:
32.58
EPS:
0.6399
Netto-Cashflow:
$355.38M
1W Leistung:
+2.08%
1M Leistung:
+3.35%
6M Leistung:
+9.42%
1J Leistung:
+23.64%
1-Tages-Spanne:
$20.57
$21.02
1-Wochen-Bereich:
$20.26
$21.05
52-Wochen-Spanne:
$15.75
$21.07
Sabra Healthcare Reit Inc Stock (SBRA) Company Profile
Firmenname
Sabra Healthcare Reit Inc
Sektor
Telefon
888-393-8248
Adresse
1781 FLIGHT WAY, TUSTIN, CA
Compare SBRA vs WELL, VTR, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBRA
Sabra Healthcare Reit Inc
|
20.86 | 5.24B | 773.78M | 155.51M | 355.38M | 0.6399 |
|
WELL
Welltower Inc
|
208.55 | 143.88B | 10.83B | 961.84M | 2.11B | -0.7091 |
|
VTR
Ventas Inc
|
87.08 | 40.94B | 5.83B | 261.52M | 1.32B | 0.5422 |
|
OHI
Omega Healthcare Investors Inc
|
48.76 | 14.31B | 1.08B | 448.00M | 779.91M | 1.61 |
|
DOC
Healthpeak Properties Inc
|
17.11 | 11.75B | 2.80B | -10.95M | 1.15B | -0.0564 |
|
AHR
American Healthcare Reit Inc
|
52.59 | 9.80B | 2.07B | -37.81M | 84.15M | -0.27 |
Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | UBS | Neutral |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-01-17 | Herabstufung | Truist | Buy → Hold |
| 2025-01-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-12-05 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-10-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-03 | Eingeleitet | Wedbush | Outperform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-27 | Eingeleitet | Berenberg | Hold |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-11-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2022-04-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-02-18 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-09-30 | Hochstufung | Truist | Hold → Buy |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-05-21 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-13 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-01-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2020-12-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-06-23 | Hochstufung | Scotiabank | Sector Underperform → Sector Perform |
| 2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
| 2020-05-18 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-02-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-02-05 | Eingeleitet | Berenberg | Hold |
| 2019-12-20 | Eingeleitet | Mizuho | Neutral |
| 2019-12-18 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-10-14 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2018-12-18 | Herabstufung | SunTrust | Buy → Hold |
| 2018-11-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-05-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-03-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Stifel | Hold |
| 2017-12-21 | Herabstufung | Jefferies | Buy → Hold |
| 2017-09-25 | Eingeleitet | CapitalOne | Equal Weight |
Alle ansehen
Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten
Truist raises Sabra Healthcare REIT price target to $22 on fundamentals - Investing.com
Sabra Healthcare REIT, Inc. $SBRA Position Boosted by Bank of Montreal Can - MarketBeat
Engineers Gate Builds $85 Million Position in Net-Lease Retail REIT Agree Realty - The Motley Fool
Schroder Investment Management Group Grows Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Duff & Phelps Investment Management Co. Cuts Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Purchased by Barclays PLC - MarketBeat
Sabra Health Care REIT, Inc. to Participate in Deutsche Bank’s 2026 Healthcare REIT Summit - Business Wire
Victory Capital Management Inc. Buys 124,207 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Sabra Health Care REIT Hits New 52-Week High at $20.88 - Markets Mojo
Sabra Health Care REIT, Inc. Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo
Sabra Health Care REIT Hits New 52-Week High at $21.07 - Markets Mojo
Sabra Health Care (SBRA) director granted 781 dividend-equivalent units - Stock Titan
[Form 4] Sabra Health Care REIT, Inc. Insider Trading Activity - Stock Titan
Director Lynne Katzmann receives 781 SBRA stock units under 2009 plan - Stock Titan
Sabra Health Care REIT (SBRA) director credited 781 dividend-equivalent stock units - Stock Titan
Director at Sabra Health Care REIT (SBRA) receives 781 stock units award - Stock Titan
Dividend-based 781-unit stock grant to Sabra (SBRA) board director - Stock Titan
Sabra Health Care REIT (SBRA) EVP granted dividend-equivalent stock units - Stock Titan
Sabra Health Care (SBRA) EVP credited 478 dividend stock units - Stock Titan
Sabra Health Care REIT (SBRA) CEO awarded 13,358 stock units - Stock Titan
Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $21.00 - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by Citigroup Inc. - MarketBeat
Sabra Healthcare earnings up next: Can REIT recover from Q3 miss? - Investing.com Nigeria
Sabra Health Care: Leveraging SHOP To Capture Silver Tsunami Tailwinds (NASDAQ:SBRA) - Seeking Alpha
Sabra Healthcare REIT stock hits 52-week high at 20.71 USD - Investing.com
Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 12-Month HighHere's What Happened - MarketBeat
Sabra Healthcare REIT stock hits 52-week high at 20.71 USD By Investing.com - Investing.com South Africa
Does Sabra’s 2026 Earnings Outlook and Triple-Net Cash NOI Guidance Change The Bull Case For SBRA? - simplywall.st
JPMorgan Chase & Co. Boosts Stock Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Purchased by Vanguard Group Inc. - MarketBeat
Greenland Capital Management LP Makes New $4.19 Million Investment in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
SBRA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Healthcare REITs, Skilled Nursing Real Estate Gain Momentum Amid Aging Demographics and Stable Income Growth - The Globe and Mail
Presima Securities ULC Reduces Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Rhumbline Advisers Sells 50,284 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Citizens Jmp Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price - Defense World
What 4 Analyst Ratings Have To Say About Sabra Health Care REIT - Benzinga
Sabra Healthcare REIT (NASDAQ:SBRA) Given New $23.00 Price Target at Citizens Jmp - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Reaches New 12-Month HighHere's Why - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by Advisors Capital Management LLC - MarketBeat
Sabra Health Care REIT ‘off to strong start,’ with 92 percent of $240M in upcoming deals in senior living - McKnight's Senior Living
Is It Time To Reassess Sabra Health Care REIT (SBRA) After Its Strong 1 Year Rally? - Yahoo Finance
Evaluating Sabra Health Care REIT (SBRA) After Its Recent Share Price Momentum - Yahoo Finance
Why Sabra Health Care REIT (SBRA) Is Up 6.0% After 2025 Earnings And 2026 Dividend Guidance - Yahoo Finance
Lumentum Analyst Starts Coverage Optimistically; Check Out Tuesday's Top 5 Initiations - Intellectia AI
Brokerages Set Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Price Target at $21.11 - Defense World
Analysts Are Neutral on Top Real Estate Stocks: Sabra Healthcare REIT (SBRA), Public Storage (PSA) - The Globe and Mail
Sabra Healthcare REIT Q1 2026 slides: Targeting 5% FFO growth with diversified portfolio - Investing.com Nigeria
Sabra Health Care REIT, Inc. (SBRA) Shares Steady as Managed Senior Housing Drives 2025 Growth - AlphaStreet News
Why Sabra Health Care REIT (SBRA) Is Up 5.6% After 2025 Results And 2026 Earnings Guidance - simplywall.st
Finanzdaten der Sabra Healthcare Reit Inc-Aktie (SBRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):